VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
QGENQiagen N.V.
$36.95$7.6B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. Financial Ratios
  3. Quarterly

  1. Home
  2. QGEN
  3. Financial Ratios
  4. Quarterly

Qiagen N.V. (QGEN) Quarterly Financial Ratios

Last 47 quarters of trend data · Healthcare · Medical - Diagnostics & Research

← View 30-Year Annual Ratios

Valuation Multiples

Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.

Qiagen N.V.'s quarterly P/E stands at 21.6x, down 22.6% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has expanded 27.5% YoY to 21.2x, reflecting rising market expectations or slowing EBITDA growth.

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
P/E Ratio →18.1121.6218.6227.3124.4827.9326.63—30.7126.1630.6833.1632.04
—-22.6%-30.1%—-20.3%+6.7%-13.2%—-4.2%-20.8%+0.9%+11.3%+65.3%
P/S Ratio3.644.324.584.914.574.795.234.735.465.065.055.395.61
—-9.8%-12.4%+4.0%-16.3%-5.4%+3.6%-12.4%-2.7%-14.7%+0.2%-3.4%+17.9%
P/B Ratio2.032.472.672.992.592.802.972.752.782.712.602.953.06
—-11.7%-10.1%+8.6%-6.8%+3.4%+14.4%-6.5%-9.0%-20.6%-14.0%-16.0%-17.1%
P/FCF16.8019.9320.5121.7423.0617.6019.0218.3626.4425.9928.7233.2281.25
—+13.2%+7.8%+18.4%-12.8%-32.3%-33.8%-44.7%-67.5%-31.6%+110.9%+55.1%+359.3%
EV / EBITDA11.8121.179.9916.3315.0916.6017.66—18.4417.4617.7819.0920.86
—+27.5%-43.4%—-18.2%-5.0%-0.7%—-11.6%-14.2%-5.1%+3.5%+65.2%
EV / EBIT16.2021.2918.4220.8218.9419.9522.37—24.4521.5723.2925.8125.18
—+6.7%-17.7%—-22.5%-7.5%-3.9%—-2.9%-19.7%-5.9%+4.7%+60.4%

Profitability

Quarterly margins and returns. Watch for margin compression across consecutive quarters.

Qiagen N.V.'s operating margin was 28.5% in Q4 2025, up 4.2 pp QoQ and up 5.6 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 24.9% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 8.2% YoY, suggesting cost inflation or competitive pricing pressure.

Margins

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Gross Margin61.8%58.7%62.2%62.7%63.8%63.9%61.4%7.0%63.4%62.1%62.6%63.1%63.3%
—-8.2%+1.2%+794.6%+0.7%+3.0%-1.9%-88.9%+0.1%-2.6%-2.6%-1.8%-4.1%
Operating Margin24.9%28.5%24.3%22.8%23.9%22.9%22.3%-46.0%20.7%21.7%20.4%21.3%19.9%
—+24.6%+8.6%+149.6%+15.3%+5.2%+9.4%-316.0%+3.9%+3.5%+4.5%-10.1%-39.5%
Net Margin20.3%20.0%24.4%18.0%18.8%16.9%19.5%-37.0%17.6%19.2%16.4%16.3%17.5%
—+17.7%+25.0%+148.8%+6.8%-11.7%+19.5%-326.4%+0.4%+7.5%-0.8%-12.9%-29.1%

Return on Capital

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
ROE11.6%2.9%3.6%2.8%2.6%2.5%2.8%-5.2%2.2%2.6%2.1%2.2%2.4%
—+16.7%+28.5%+153.2%+19.5%-4.4%+32.9%-332.9%-10.0%-0.4%-14.7%-24.1%-50.6%
ROA7.1%1.7%2.1%1.7%1.6%1.5%1.7%-3.2%1.4%1.6%1.3%1.3%1.4%
—+13.6%+27.0%+152.6%+19.4%-9.1%+30.2%-351.7%+0.0%+17.1%-2.3%-18.3%-46.3%
ROIC8.6%2.6%2.2%2.2%2.0%2.0%1.9%-3.9%1.5%1.8%1.5%1.6%1.5%
—+28.9%+16.7%+156.3%+31.7%+12.9%+25.2%-344.1%+1.1%+0.6%-7.2%-22.8%-58.6%

Leverage & Debt

Quarterly solvency trend — watch for debt spikes or covenant pressure.

Qiagen N.V.'s Debt/EBITDA ratio is 13.8x, up from 8.1x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 8.1% YoY to 3.90x, strengthening the short-term liquidity position.

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Debt / Equity0.440.440.580.410.410.450.540.410.420.440.400.520.53
—-2.9%+7.2%+0.1%-1.0%+1.6%+35.5%-21.0%-20.9%-18.3%-41.6%-11.6%-12.0%
Debt / EBITDA2.3213.798.078.438.849.7711.84—10.0710.4210.0412.0612.64
—+41.1%-31.8%—-12.2%-6.2%+18.0%—-20.3%-11.9%-35.1%+7.5%+69.1%
Current Ratio3.903.902.601.613.373.612.171.771.841.993.742.362.53
—+8.1%+19.6%-8.8%+82.8%+81.2%-41.9%-25.2%-27.1%-19.0%+103.4%+6.0%+15.4%
Quick Ratio3.313.312.301.352.833.091.891.461.451.622.981.962.10
—+6.9%+21.8%-7.2%+94.6%+90.8%-36.6%-25.7%-30.9%-22.4%+83.6%+3.7%+13.3%
Interest Coverage15.7411.7717.3917.6817.3912.2911.14-19.4610.9410.568.678.588.53
—————————————

Download Financial Ratios Data

Includes 30+ ratios · 47 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

QGEN — Frequently Asked Questions

Quick answers to the most common questions about buying QGEN stock.

What is Qiagen N.V.'s quarterly P/E ratio trend?

Qiagen N.V.'s current P/E is 18.1x. The average P/E over the last 4 quarters is 23.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.

How do Qiagen N.V.'s margins change by quarter?

Qiagen N.V.'s current operating margin is 24.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.

Why look at QGEN quarterly ratios instead of annual?

Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Qiagen N.V.'s business trajectory between earnings reports.